Elitra Pharmaceuticals Inc.

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 20.0

Forward Citations = 35

Loading Chart...

15 inventors (with patents filed for the assignee):

Judith W Zyskind (3 out of 6 patents)

Kari Lynn Ohlsen (2 out of 5 patents)

R Allyn Forsyth (2 out of 4 patents)

4. John D Trawick (1 out of 25 patents)

5. Charles Boone (1 out of 6 patents)

6. Terry Roemer (1 out of 3 patents)

7. Howard Bussey (1 out of 7 patents)

8. Chandra Patterson (1 out of 40 patents)

9. Bo Jiang (1 out of 1 patent)

10. Jamie M Froelich (1 out of 1 patent)

11. Robert T Yamamoto (1 out of 1 patent)

12. H Howard Xu (1 out of 1 patent)

13. Grant J Carr (1 out of 1 patent)

14. Robert E Lagace (1 out of 1 patent)

15. Kim L Berg (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 6783985 - Gene disruption methodologies for drug target discovery (2004-08-31),

2. 6720139 - Genes identified as required for proliferation in Escherichia coli (2004-04-13),

3. 6632636 - Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis (2003-10-14),

4. 6620585 - Use of ectoenzymes and secreted enzymes to monitor cellular proliferation (2003-09-16),

5. 6589738 - Genes essential for microbial proliferation and antisense thereto (2003-07-08),

Company Overview

Elitra Pharmaceuticals Inc. is a leading biopharmaceutical company focused on the development of innovative therapies for various diseases. With a strong emphasis on research and development, Elitra Pharmaceuticals Inc. strives to bring new and advanced treatment options to patients worldwide. Our team of dedicated scientists and researchers work tirelessly to discover groundbreaking solutions that improve the lives of individuals in need.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#875 in San Diego, CA

#12,079 in California

#51,669 in US

San Diego, CA, United States of America